Compile Data Set for Download or QSAR
maximum 50k data
Found 24 Enz. Inhib. hit(s) with all data for entry = 9040
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436175(US10610125, Example Table 24a.1)
Affinity DataIC50:  5.74E+3nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436667(US10610125, Example Table 24a.2)
Affinity DataIC50:  5.92E+3nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436668(US10610125, Example Table 24a.3)
Affinity DataIC50:  8.61E+3nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436667(US10610125, Example Table 24a.2)
Affinity DataIC50:  1.23E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436670(US10610125, Example Table 24a.5)
Affinity DataIC50:  1.28E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436668(US10610125, Example Table 24a.3)
Affinity DataIC50:  1.28E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436668(US10610125, Example Table 24a.3)
Affinity DataIC50:  1.47E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436669(US10610125, Example Table 24a.4)
Affinity DataIC50:  1.50E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436175(US10610125, Example Table 24a.1)
Affinity DataIC50:  1.62E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase B chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436667(US10610125, Example Table 24a.2)
Affinity DataIC50:  1.74E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436669(US10610125, Example Table 24a.4)
Affinity DataIC50:  1.92E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436668(US10610125, Example Table 24a.3)
Affinity DataIC50:  1.92E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436670(US10610125, Example Table 24a.5)
Affinity DataIC50:  2.38E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436175(US10610125, Example Table 24a.1)
Affinity DataIC50:  2.54E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436670(US10610125, Example Table 24a.5)
Affinity DataIC50:  3.32E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436669(US10610125, Example Table 24a.4)
Affinity DataIC50:  3.38E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436667(US10610125, Example Table 24a.2)
Affinity DataIC50:  4.14E+4nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436669(US10610125, Example Table 24a.4)
Affinity DataIC50:  4.68E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase B chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436175(US10610125, Example Table 24a.1)
Affinity DataIC50:  6.41E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436670(US10610125, Example Table 24a.5)
Affinity DataIC50:  6.93E+4nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase B chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436670(US10610125, Example Table 24a.5)
Affinity DataIC50: >1.00E+5nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase B chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436668(US10610125, Example Table 24a.3)
Affinity DataIC50: >1.00E+5nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetL-lactate dehydrogenase B chain(Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436669(US10610125, Example Table 24a.4)
Affinity DataIC50: >1.00E+5nMAssay Description:All reactions were performed in standard enzyme reaction buffer (150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 10% glycerol, 5 mM MgCl2 and 0.03% (w/v) bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Homo sapiens (Human))
Agios Pharmaceuticals

US Patent
LigandPNGBDBM436175(US10610125, Example Table 24a.1)
Affinity DataIC50: >1.00E+5nMAssay Description:Assays were conducted in a volume of 76 ul assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in a sta...More data for this Ligand-Target Pair
In DepthDetails US Patent